Page 2 - பெருநிறுவன தகவல்தொடர்புகள் முதலீட்டாளர் உறவுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Athersys Partner HEALIOS K K Completes Enrollment in the TREASURE Study of MultiStem Treatment for Ischemic Stroke
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Athersys and HEALIOS K K Announce Advancement of Their MultiStem Commercial Partnership
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Aptose Reports Results for the Second Quarter 2021
Aptose Biosciences Inc. a clinical-stage company developing highly differentiated agents that target the underlying mechanisms of cancer, today announced financial results for the three months ended June 30, 2021 and provided a corporate update. The net loss for the quarter ended June 30, 2021 was $13.5 million compared with $15.8 million for the quarter ended June 30, 2020. The net loss for the six months ended … – Conference call and webcast at 5:00 pm EDT today – – Luxeptinib Phase 1a/b studies in AML and B cell malignancies fully enrolled at 750 mg dose – – APTO-253 Phase 1a/b study in AML / MDS treating patients at sixth dose cohort of 210 mg/m2 –
Operator
Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions]. Following the presentation, there will be a question-and-answer session. [Operator Instructions]
I would now like to hand the conference over to Ben Church, Investor Relations and Corporate Communications at Esperion. Please go ahead, sir.
Benjamin Church
Head, Corporate Communications & Investor Relations
Thank you, operator. Good morning and welcome to Esperion s Second Quarter 2021 Financial Results and Company Update Conference Call. I m Ben Church and I m responsible for Investor Relations and Corporate Communications here at Esperion.
I want to remind callers that the information discussed on the call today is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements.
Operator
Welcome to the OraSure Technologies Incorporated 2021 Second Quarter Earnings Conference Call. My name is Adrian, and I ll be your operator for today s call. [Operator Instructions] Later, we ll conduct a question-and-answer session. [Operator Instructions]
I ll now turn the call over to Scott Gleason, Head of Investor Relations at OraSure. Mr. Gleason, you may begin.
Scott Gleason
Senior Vice President, Corporate Communications & Investor Relations
Thank you. Good afternoon, and welcome to OraSure Technologies second quarter 2021 earnings call. I am Scott Gleason, the Senior Vice President of Investor Relations and Communications. Presenting forward for today are Dr. Stephen Tang, our President and Chief Executive Officer; and Roberto Cuca, our Chief Financial Officer. As a reminder, today s webcast is being recorded and a slide presentation accompanying the webcast can be found on the Investor Relations website.
vimarsana © 2020. All Rights Reserved.